Evaluation of the efficacy and safety of romosozumab (evenity) for the treatment of osteoporotic vertebral compression fracture in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials (CDM-J).
Wenbo HuangMasashi NagaoNaohiro YonemotoSen GuoTakeshi TanigawaYuji NishizakiPublished in: Pharmacoepidemiology and drug safety (2023)
Our meta-analysis revealed the evident advantages of romosozumab in the treatment of osteoporosis and low BMD in postmenopausal women and increased risks of hypersensitivity and injection site reactions.